Newsletter
MHRP Exchange Spring 2022
In this issue:
- New HIV Vaccine Trial to Test ALFQ Adjuvant, Fractional Dosing
- MHRP Begins Preclinical Testing of mRNA HIV Vaccine
- Monoclonal Antibody Research Seeks New HIV Prevention Tools
